Clinical Research Directory

Inclusion Criteria: * Biological Female * Previously established clinical diagnosis of Interstitial Cystitis/ Bladder Pain Syndrome (IC/BPS) * Diagnosed with High-tone Pelvic Floor Dysfunction (HTPFD) * Current pelvic pain score of 5 or greater on an 11-point Likert Scale * Must be willing and able to insert intravaginal device * No cognitive deficits * Agrees not to commence any new treatments for HTPFD or IC/BPS (medical or physical therapy) during the 12-week intervention period Exclusion Criteria: * History of a spinal cord injury * Currently pregnant or lactating * Allergy to device materials * Active vaginal infection (e.g. vulvovaginal candidiasis, trichomonas, vaginitis, bacterial vaginosis, STIs, etc.) * Have open wounds, cuts, or open sores present in the vaginal or pelvic area * Recent pelvic or abdominal surgery within the last 3 months * Currently under the care of a pelvic floor physical therapist or pelvic floor physiotherapist * History of Neurogenic bladder * History of bladder, uterine, ovarian or vaginal cancer * History of radiation cystitis * Any pelvic floor/bladder Botox use within 6 months of enrollment and no future plans for Botox injections during the study period. * Any other medical condition or clinical finding giving reasonable suspicion of a disease or condition that contraindicates the use of the Floora, at the discretion of the Investigator